百奥泰：公司已建立完善的人才梯队并持续引进优秀人才

Core Viewpoint - The company emphasizes the uncertainty in the drug approval process and is committed to advancing its applications while ensuring timely information disclosure to investors [2]. Group 1: Company Operations - The company has established a robust talent pipeline and continues to attract top talent, which supports stable operations in research and innovation [2]. - The company remains focused on its core business and is actively advancing its research and commercialization efforts [2]. Group 2: Future Outlook - The introduction of more products is expected to gradually improve and enhance the company's operational performance [2].